A Clinical Outcomes Study to Measure Reduction in Pain and Numbness During Administration of an Amino Acid Formulation in Subjects Diagnosed With Peripheral Neuropathy

NCT01537705 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Neuropathy
Chemotherapy Induced Neuropathy
HIV Neuropathy
Trauma Induced Neuropathy

Interventions

DRUG: Neuron012703 (Medical Food)

Sponsor

Targeted Medical Pharma